Unknown NA INTERVENTIONAL 1-arm NCT02390622

Biotherapy for MRSA Enterocolitis

Fecal Microbiota Transplantation Restores Dysbiosis in Patients With Methicillin Resistant Staphylococcus Aureus Enterocolitis

Sponsor: Jinling Hospital, China

Conditions Methicillin-Resistant Staphylococcus Aureus

Interventions Fecal microbiota transplantation

Updated 5 times since 2017 Last updated: Mar 11, 2015 Started: Jul 31, 2013 Primary completion: Feb 29, 2016 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Methicillin-Resistant Staphylococcus Aureus and is currently ongoing. Jinling Hospital, China leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
May 2017 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — May 2017 [monthly]

Recruiting NA

First recorded

Jul 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jinling Hospital, China

Data source: Jinling Hospital, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China